Stocksigma LogoStocksigma Logo

Sun Pharma Approves Up to ₹10,000 Crore NCD Issuance; Director Resigns

Sun Pharmaceutical Industries' Board approved the issuance of listed, rated, unsecured, redeemable non-convertible debentures (NCDs) on a private placement

Sun Pharma Approves Up to ₹10,000 Crore NCD Issuance; Director Resigns

Sun Pharmaceutical Industries Ltd · Change in Management · 13 Oct 2026, 1:34 am

Sun Pharma Approves Up to ₹10,000 Crore NCD Issuance; Director Resigns Sun Pharmaceutical Industries' Board approved the issuance of listed, rated, unsecured, redeemable non-convertible debentures (NCDs) on a private placement basis for up to ₹10,000 Crore in one or more tranches. The Board also authorized its Finance Committee to finalize tranche-specific terms and allotment details. Additionally, Non-Executive Independent Director Gautam Doshi resigned with immediate effect on 12th Oct'26, citing personal commitments, simultaneously stepping down from board committees and subsidiary directorships with no other material reasons reported.

Original exchange filing (PDF)

More announcements from Sun Pharmaceutical Industries Ltd

All Sun Pharmaceutical Industries Ltd announcements